572 results
P
pacientes con COVID-19
I/C
inhibidores de la enzima convertidora de angiotensina, bloqueadores del receptor de angiotensina II, placebo o ningún tratamiento
O
efectos sobre la COVID-19
P
I+C, I, C
I/C
PD-1/L1 inhibitors plus chemotherapy, PD-1/L1 inhibitors alone, chemotherapy, I+C vs I, I+C vs C, I vs C
O
risk of immune-related pneumonitis (IRP), risk of any grade IRP, risk of grade 3-5 IRP
P
pacientes sometidos a cirugía
I/C
intervenciones con ejercicio, controlados
O
reducción de la sarcopenia
P
CHROMATRYPSIN C
I/C
CHROMATRYPSIN C, CHROMATRYPSIN C
O
CHRONIC PANCREATITIS
P
adolescents, dual users (combustible- plus electronic- cigarettes users), electronic nicotine delivery systems (ENDS) users, never- or past- electronic nicotine delivery systems users
I/C
electronic nicotine delivery systems (ENDS), c-cigarettes, c-cig, dual users (combustible- plus electronic- cigarettes users) versus combustible-cigarettes users, electronic nicotine delivery systems (ENDS) users versus never- or past- electronic nicotine delivery systems users
O
proportion of complete or partial substitution of conventional to electronic cigarettes, odds ratio of quitting combustible cigarettes among electronic nicotine delivery systems users, prevalence of electronic cigarettes use, relationship between consumption and price increase of electronic and combustible cigarettes
P
patients with de novo IAs
I/C
systematic review and meta-analysis of existing de novo IA cohorts, initial IAs in the middle cerebral artery
O
de novo IAs
P
COVID-19 patients, non-COVID-19 pneumonia patients
I/C
leukocyte count, neutrophil count, thrombocyte count, lymphocyte count, C-reactive protein (CRP), procalcitonin (PCT), D-dimer, COVID-19 vs non-COVID-19 pneumonia, severe COVID-19 vs non-severe COVID-19
O
diagnosis, prognosis, severity of COVID-19
P
surgical patients
I/C
peripheral levels of Insulin-like Growth Factor-1 (IGF-1), C-Reactive Protein (C-RP) and Interleukin-6 (IL-6), delirium in surgical patients
O
association between peripheral levels of IGF-1, C-RP and IL-6 and delirium
P
patients with risk factors for surgical-site complications
I/C
prophylactic use of a specific single-use negative-pressure wound therapy (sNPWT) device, conventional dressings
O
surgical-site infection (SSI), wound dehiscence, seroma, necrosis, mean length of hospital stay
P
FinnGen, UK Biobank
I/C
vitamin C, circulating vitamin C
O
risk of small intestine and colorectal cancer